| Reference |
|---|
Lin I, Lin Y, Chang Y, Kondapuram S, Lin K, Chen P, et al. The SMAC mimetic GDC-0152 is a direct ABCB1-ATPase activity modulator and BIRC5 expression suppressor in cancer cells. Toxicol Appl Pharmacol. 2024;485:116888 pubmed publisher |
Delgado A, Griera R, Llor N, L xf3 pez Aguilar E, Busquets M, No xe9 V, et al. Trioleyl Pyridinium, a Cationic Transfection Agent for the Lipofection of Therapeutic Oligonucleotides into Mammalian Cells. Pharmaceutics. 2023;15: pubmed publisher |
Carrasco N, Garrido M, Montenegro I, Madrid A, Hartley R, Gonz xe1 lez I, et al. Antitumoral Activity of Leptocarpha rivularis Flower Extracts against Gastric Cancer Cells. Int J Mol Sci. 2023;24: pubmed publisher |
Woo S, Kim S, Seo S, Kim S, Park J, Kim G, et al. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5. Cell Death Dis. 2022;13:821 pubmed publisher |
Danielpour D, Corum S, Leahy P, Bangalore A. Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism. Curr Res Pharmacol Drug Discov. 2022;3:100117 pubmed publisher |
Chang Y, Shieh M, Chang Y, Huang W, Su W, Cheng F, et al. Development of a cancer cells self‑activating and miR‑125a‑5p expressing poly‑pharmacological nanodrug for cancer treatment. Int J Mol Med. 2022;50: pubmed publisher |
Mohammadhosseinpour S, Ho L, Fang L, Xu J, Medina Bolivar F. Arachidin-1, a Prenylated Stilbenoid from Peanut, Induces Apoptosis in Triple-Negative Breast Cancer Cells. Int J Mol Sci. 2022;23: pubmed publisher |
Danielpour D, Corum S, Welford S, Shankar E. Hypoxia represses early responses of prostate and renal cancer cells to YM155 independent of HIF-1α and HIF-2α. Curr Res Pharmacol Drug Discov. 2022;3:100076 pubmed publisher |
Aubets E, Chillon M, Ciudad C, Noe V. PolyPurine Reverse Hoogsteen Hairpins Work as RNA Species for Gene Silencing. Int J Mol Sci. 2021;22: pubmed publisher |
Hakim S, Abou Gabal H. Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study. Pathol Oncol Res. 2021;27:600073 pubmed publisher |
Jugel W, Aigner A, Michen S, Hagstotz A, Ewe A, Appelhans D, et al. Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors. Pharmaceutics. 2021;13: pubmed publisher |
Ren Y, Wang X, Huang S, Xu Y, Weng G, Yu R. Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis. Front Pharmacol. 2021;12:560903 pubmed publisher |
Güllülü Ö, Hehlgans S, Mayer B, Gößner I, Petraki C, Hoffmann M, et al. A Spatial and Functional Interaction of a Heterotetramer Survivin-DNA-PKcs Complex in DNA Damage Response. Cancer Res. 2021;81:2304-2317 pubmed publisher |
Rodrigues Moita A, Bandolik J, Hansen F, Kurz T, Hamacher A, Kassack M. Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. Int J Mol Sci. 2020;21: pubmed publisher |
Garrido M, Salvatierra R, Valenzuela Valderrama M, Vallejos C, Bruneau N, Hernandez A, et al. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals (Basel). 2020;13: pubmed publisher |
Schweitzer K, Jinawath N, Yonescu R, Ni K, Rush N, Charoensawan V, et al. IGSF3 mutation identified in patient with severe COPD alters cell function and motility. JCI Insight. 2020;5: pubmed publisher |
Lee Y, Song S, Hong H, Oh B, Lee W, Cho Y. The FBW7-MCL-1 axis is key in M1 and M2 macrophage-related colon cancer cell progression: validating the immunotherapeutic value of targeting PI3Kγ. Exp Mol Med. 2020;52:815-831 pubmed publisher |
Nishisaka F, Taniguchi K, Tsugane M, Hirata G, Takagi A, Asakawa N, et al. Antitumor activity of a novel oral signal transducer and activator of transcription 3 inhibitor YHO-1701. Cancer Sci. 2020;111:1774-1784 pubmed publisher |
Garrido M, Hurtado I, Valenzuela Valderrama M, Salvatierra R, Hernandez A, Vega M, et al. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE2 Signaling Axis. Cancers (Basel). 2019;11: pubmed publisher |
Lin T, Chan H, Chen S, Sarvagalla S, Chen P, Coumar M, et al. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells. Autophagy. 2019;:1-18 pubmed publisher |
Fitzpatrick C, Bendek M, Briones M, Farfan N, Silva V, Nardocci G, et al. Mitochondrial ncRNA targeting induces cell cycle arrest and tumor growth inhibition of MDA-MB-231 breast cancer cells through reduction of key cell cycle progression factors. Cell Death Dis. 2019;10:423 pubmed publisher |
Tsai S, Chang Y, Sarvagalla S, Wang S, Coumar M, Cheung C. Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli. Protein Expr Purif. 2019;160:73-83 pubmed publisher |
Ahmed R, Shaughnessy D, Knutson T, Vogel R, Ahmed K, Kren B, et al. CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells. Pharmaceuticals (Basel). 2019;12: pubmed publisher |
Linder B, Wehle A, Hehlgans S, Bonn F, Dikic I, Rodel F, et al. Arsenic Trioxide and (-)-Gossypol Synergistically Target Glioma Stem-Like Cells via Inhibition of Hedgehog and Notch Signaling. Cancers (Basel). 2019;11: pubmed publisher |
Hehlgans S, Booms P, Güllülü Ö, Sader R, Rodel C, Balermpas P, et al. Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib. Int J Mol Sci. 2018;19: pubmed publisher |
Jiang X, Mak P, Mu H, Tao W, Mak D, Kornblau S, et al. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia. Clin Cancer Res. 2018;24:2417-2429 pubmed publisher |
Conde M, Michen S, Wiedemuth R, Klink B, Schrock E, Schackert G, et al. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells. BMC Cancer. 2017;17:889 pubmed publisher |
Reich T, Switzeny O, Renovanz M, Sommer C, Kaina B, Christmann M, et al. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome. Oncotarget. 2017;8:15071-15084 pubmed publisher |
Mędra A, Witkowska M, Majchrzak A, Cebula Obrzut B, Bonner M, Robak T, et al. Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies. Molecules. 2016;21: pubmed publisher |
Engel K, Rudelius M, Slawska J, Jacobs L, Ahangarian Abhari B, Altmann B, et al. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma. EMBO Mol Med. 2016;8:851-62 pubmed publisher |
Lin K, Cheng S, Tsai S, Tsai J, Lin C, Cheung C. Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study. Onco Targets Ther. 2016;9:2601-13 pubmed publisher |
